TY - JOUR
T1 - Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma
AU - Voit, Christiane
AU - Van Akkooi, Alexander C.J.
AU - Schäfer-Hesterberg, Gregor
AU - Schoengen, Alfred
AU - Kowalczyk, Katharina
AU - Roewert, Joachim C.
AU - Sterry, Wolfram
AU - Eggermont, Alexander M.M.
PY - 2010/2/10
Y1 - 2010/2/10
N2 - Purpose: We have shown that ultrasound (US) -guided fine needle aspiration cytology (FNAC) can accurately identify the sentinel node (SN). Moreover, US-guided FNAC before the surgical SN procedure could identify up to 65% of all SN metastases. Herein we analyzed in detail the different US morphologic patterns of SN metastases. Patients and Methods: From July 2001 to December 2007, a total of 650 patients with melanoma scheduled for sentinel lymph node dissection were examined. We present the first 400 with sufficient follow-up (mean 40, median 39 months). Several morphologic characteristics were scored. In case of suspicious/ clearly malignant US patterns a FNAC was performed. The final histology was considered the gold standard. Results: Median Breslow was 1.8 mm. The sensitivity and positive predictive value of the most important factors were: peripheral perfusion (PP) present (77% and 52%, respectively), loss of central echoes (LCE; 60% and 65% respectively), and balloon shape (BS; 30% and 96% respectively). Together these factors have a sensitivity of 82% and PPV of 52% (P < .001). PP identified more patients with lower volume disease. PP and combined BS and LCE were independent prognostic factors for survival (hazard ratio, 2.19; P < .015; and hazard ratio, 5.50; P < .001, respectively). Conclusion: Preoperative US and FNAC can identify 65% of SN metastases and thus reduce the need for surgical SN procedures. Peripheral perfusion is an early sign of involvement and of crucial importance to achieve a high identification rate. Balloon shape and loss of central echoes are late signs of metastases. We recommend US evaluation to identify those patients, who can directly proceed to a complete lymph node dissection after a positive US-guided FNAC of the SN.
AB - Purpose: We have shown that ultrasound (US) -guided fine needle aspiration cytology (FNAC) can accurately identify the sentinel node (SN). Moreover, US-guided FNAC before the surgical SN procedure could identify up to 65% of all SN metastases. Herein we analyzed in detail the different US morphologic patterns of SN metastases. Patients and Methods: From July 2001 to December 2007, a total of 650 patients with melanoma scheduled for sentinel lymph node dissection were examined. We present the first 400 with sufficient follow-up (mean 40, median 39 months). Several morphologic characteristics were scored. In case of suspicious/ clearly malignant US patterns a FNAC was performed. The final histology was considered the gold standard. Results: Median Breslow was 1.8 mm. The sensitivity and positive predictive value of the most important factors were: peripheral perfusion (PP) present (77% and 52%, respectively), loss of central echoes (LCE; 60% and 65% respectively), and balloon shape (BS; 30% and 96% respectively). Together these factors have a sensitivity of 82% and PPV of 52% (P < .001). PP identified more patients with lower volume disease. PP and combined BS and LCE were independent prognostic factors for survival (hazard ratio, 2.19; P < .015; and hazard ratio, 5.50; P < .001, respectively). Conclusion: Preoperative US and FNAC can identify 65% of SN metastases and thus reduce the need for surgical SN procedures. Peripheral perfusion is an early sign of involvement and of crucial importance to achieve a high identification rate. Balloon shape and loss of central echoes are late signs of metastases. We recommend US evaluation to identify those patients, who can directly proceed to a complete lymph node dissection after a positive US-guided FNAC of the SN.
UR - http://www.scopus.com/inward/record.url?scp=77649224567&partnerID=8YFLogxK
U2 - 10.1200/JCO.2009.25.7428
DO - 10.1200/JCO.2009.25.7428
M3 - Article
C2 - 20065175
AN - SCOPUS:77649224567
SN - 0732-183X
VL - 28
SP - 847
EP - 852
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 5
ER -